Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment

• Published in: Chinese medical journal Vol. 120; no. 9; pp. 782 - 786
• Main Authors: Jiang, Xiao, Sheng, Hai-hui, Lin, Gang, Li, Jian, Lu, Xin-zheng, Cheng, Yun-lin, Huang, Jun, Xiao, Hua-sheng, Zhan, Yi-yang
• Format: Journal Article
• Language: English
• Published: China Department of Geriatrics,First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China%National Engineering Center for Biochip at Shanghai, Shanghai 201203, China%Department of Cardiology, Dongtai People's Hospital of Jiangsu Province, Dongtai 224200, China%Department of Cardiology , First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China 05.05.2007
• Subjects: Aged; Angiotensinogen - genetics; Cytochrome P-450 CYP11B2 - genetics; Female; Genotype; Humans; Hydrochlorothiazide - therapeutic use; Hypertension - drug therapy; Hypertension - genetics; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Peptidyl-Dipeptidase A - genetics; Polymorphism, Single Nucleotide; 基因多态性; 抗高血压治疗; 肾素-血管紧张素-醛固酮系统; 血压反应; gene chip; essential hypertension; renin-angiotensin-aldosterone system; diuretic; single nucleotide polymorphism
• ISSN: 0366-6999; 2542-5641
• DOI: 10.1097/00029330-200705010-00009

Background The renin-angiotensin-aldosterone system （RAAS） is important for the development of essential hypertension, and many antihypertensive drugs target it. This study was undertaken to determine whether polymorphisms in the renin-angiotensin-aldosterone system are related to the blood pressure （BP） response to diuretic treatment in a Chinese Han ethnic population. Methods Fifty-four patients with essential hypertension received hydrochlorothiazide （12.5 mg, once daily） as monotherapy for four weeks. Seven polymorphisms in RAAS genes were genotyped by gene chip technology. The relationship between these polymorphisms and the change in blood pressure was observed after the 4-week treatment. Results The patients with angiotensinogen （AGT） -6G allele showed a greater reduction in diastolic BP （P=- 0.025） and mean BP （P=-0.039） than those carrying AA genotype. Patients carrying aldosterone synthase （CYP11B2） CC genotype exhibited a greater BP reduction than those carrying CT and TT genotypes （systolic BP： P=- 0.030; diastolic BP： P=- 0.026; mean BP： P=-0.003）. In addition, patients with a combination of CYP11B2 CC genotype and angiotensin converting enzyme （ACE） D allele might have a more pronounced reduction of systolic BP than those with any other genotypic combinations of the two genes （P=0.007）. Conclusions AGT-6G allele, CYP11B2 -344CC genotype and its combination with ACE D allele are associated with BP response to hydrochlorothiazide treatment. Larger studies are warranted to validate this finding.